A Novel Pathogenic Large Duplication in EXT1 Identified in a Family with Multiple Osteochondromas

Multiple osteochondromas (MO) is an autosomal dominant disorder and the most common genetic skeletal dysplasia, characterized by the growth of bone outgrowths capped by cartilage, called osteochondromas. Most MO cases are caused by mutations in the exostosin-1 (<i>EXT1</i>) and exostosin-2 (<i>EXT2</i>) genes. Only 5% of MO-causative variants are represented by single or multiple exon deletions; to date, no pathogenic large duplication has been described in the literature. In the present study, we describe the novel in-tandem intragenic duplication c.(1128_1202)_(1284+29_1344)dup involving exon 4 of <i>EXT1</i> (NM_000127.2), detected in a three-generation family with MO. The variant has been detected by MLPA (multiplex ligation-dependent probe amplification) and then confirmed with qPCR (quantitative PCR). Our finding expands the spectrum of MO-causing variants describing a pathogenic large duplication, underlying the importance of quantitative analysis in patients with negative sequencing.

Authors

Institutions

Publication Details

Journal
Genes
Published
2024-09-05
DOI
https://doi.org/10.3390/genes15091169
Citations
1
Primary Topic
Bone Tumor Diagnosis and Treatments
Type
article
Field-Weighted Citation Impact
0.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel Pathogenic Large Duplication in EXT1 Identified in a Family with Multiple Osteochondromas

Alice Moroni, Maria Gnoli, Elena Pedrini, Serena Corsini et al.
1 citations
Genes
Bone Tumor Diagnosis and Treatments
0.47
article

A Novel Pathogenic Large Duplication in EXT1 Identified in a Family with Multiple Osteochondromas

Alice Moroni, Maria Gnoli, Elena Pedrini, Serena Corsini, Luca Sangiorgi, Isabella Bartolotti, Davide Scognamiglio, Klaudia Sobul
article en
1 citations

Abstract

Multiple osteochondromas (MO) is an autosomal dominant disorder and the most common genetic skeletal dysplasia, characterized by the growth of bone outgrowths capped by cartilage, called osteochondromas. Most MO cases are caused by mutations in the exostosin-1 (<i>EXT1</i>) and exostosin-2 (<i>EXT2</i>) genes. Only 5% of MO-causative variants are represented by single or multiple exon deletions; to date, no pathogenic large duplication has been described in the literature. In the present study, we describe the novel in-tandem intragenic duplication c.(1128_1202)_(1284+29_1344)dup involving exon 4 of <i>EXT1</i> (NM_000127.2), detected in a three-generation family with MO. The variant has been detected by MLPA (multiplex ligation-dependent probe amplification) and then confirmed with qPCR (quantitative PCR). Our finding expands the spectrum of MO-causing variants describing a pathogenic large duplication, underlying the importance of quantitative analysis in patients with negative sequencing.

GenesVol. 15(9)
Istituto Ortopedico Rizzoli (IT)
Biogen, Ministero della Salute
Openalex Percentile: Top 32%
Bone Tumor Diagnosis and Treatments
0.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.